Results 231 to 240 of about 644,429 (317)

Age-dependent obesity paradox in acute myocardial infarction prognosis: a cohort study of body mass index and recurrent myocardial infarction. [PDF]

Int J Obes (Lond)
Zhang L, Liu Z, Zeng J, Wu M.
europepmc   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Beyond atherosclerosis: polycythemia vera presenting as ST-elevation myocardial infarction-a case report. [PDF]

Eur Heart J Case Rep
Panda A, Kumar S, Mishra SS.
europepmc   +1 more source

The gut-heart dialogue: an epigenetic perspective on myocardial infarction. [PDF]

NPJ Biofilms Microbiomes
Song J, Tang S, Guo Y, Hong C, Song T.
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Frailty and long-term outcomes in younger patients with acute myocardial infarction. [PDF]

Eur Heart J
Mohiaddin H, Sze S, Damluji AA, Ladwiniec A, McCann GP, Murphy GJ, James S, Gale CP, Squire I, Khan MS, Butler J, Mamas MA, Rashid M.   +12 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Periprocedural Myocardial Infarction: Do We Need an Updated Definition? [PDF]

J Cardiovasc Dev Dis
Casuso Alvarez M, Bavuso LL, Di Leo M, Basile M, Vasumini N, Manaresi T, Maida A, Moretti M, Cavallo D, Canton L, Amicone S, Fedele D, Conficoni E, Marinelli A, Carletti R, Angeli F, Bergamaschi L, Armillotta M, Pizzi C.   +18 more
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Myocardial infarction following fluorescein angiography: a case report and review of the literature. [PDF]

Front Ophthalmol (Lausanne)
El-Geneidy M, Alapati A, Ajlan RS.
europepmc   +1 more source